跳至主要内容
临床试验/KCT0009030
KCT0009030尚未招募Unknown

Study of early ovarian cancer using sentinel lymph node sampling

Asan Medical Center0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19(Year) 至 80(Year)(—)
性别
Female

入选标准

  • Age: 19-80 years
  • Pathologically confirmed or clinically suspicious stage 1 and 2 epithelial ovarian cancer patients
  • Those who are diagnosed with epithelial, Non-epithelial ovarian cancer, borderline ovarian cancer
  • No suspicious distal metastasis in CT/MRI or PET
  • Those who are planning staging surgery via laparoscopic or laparotomy
  • Those without certain organ failure
  • WBC = 3,000/mm3
  • Platelets = 100,000/mm3
  • Creatinine = 2.0 mg/dL
  • Bilirubin = 1.5 x institutional upper limit normal
  • SGOT, SGPT, and ALP = 3 x institutional upper limit normal
  • Those who signed in informed consent by their own will

排除标准

  • Those who are diagnosed other than epithelial, Non-epithelial ovarian cancer, borderline ovarian cancer
  • Suspicious distant metastasis in CT/MRI or PET
  • Clinical stage 3 or more
  • Those who are currently pregnant or breast feeding
  • Those who are diagnosed other cancer within 5 years
  • Those who have severe morbidity or complication

研究者

相似试验

Study of early ovarian cancer using sentinel lymph... | 临床试验